Echocardiographic Epicardial Adipose Tissue Thickness as a Marker of Insulin Resistance

Authors

  • Kristine Catherine Tan-Ramos Cardinal Santos Medical Center
  • Rosa Allyn Sy
  • Vivian Choa

Abstract

Objective. The main objective of this study is to determine if epicardial fat thickness can be an early marker of insulin resistance. The specific objectives are to determine the specific thickness of epicardial fat that will correlate with insulin resistance and to correlate epicardial fat thickness with co-morbidities, anthropometric measurements and other clinical variables.

Methodology. Patients were enrolled into the study by purposive sampling. Insulin assay, fasting blood sugar (FBS) and 2D echocardiogram measuring the epicardial fat were requested. HOMA-IR was computed and correlated with epicardial fat thickness. SPSS version 19 and Epi info v3.5.1 were used for statistical analysis. Linear regression analysis was performed on all variables to identify correlates with epicardial fat thickness.

Results. A total of 22 subjects were included in the study. Insulin resistance determined using HOMA-IR, as well as BMI and fasting insulin level showed significant correlation with epicardial fat thickness (p-value <0.01). Based on the analysis, 9.5 mm was found to be the most sensitive and specific measurement for epicardial fat thickness that is correlated to insulin resistance with sensitivity of 100% and specificity of 86%.

Conclusions. Epicardial fat thickness through routine 2D echocardiogram is significantly directly correlated with insulin resistance and 9.5 mm is the cut–off value for predicting insulin resistance.

Downloads

Download data is not yet available.

References

Martin WP, Martin HE, Lyster RW. Insulin resistance; Critical survey of the literature with the report of a case. J Clin Endocrinol. May 1941;1: 387-397.

Aydin H, Toprak A, Deyneli O, et al. Epicardial fat tissue thickness correlates with endothelial dysfunction and other cardiovascular risk factors in patients with Metabolic Syndrome. Metab Syndr Relat D. 2010; 8 (3):229-234. http://dx.doi.org/10.1089/met.2009.0080.

Chao-Ping W, Hui-Ling Hsu, Wei-Chin H, et al. Increased epicardial adipose tissue (EAT) volume in type 2 diabetes mellitus and association with metabolic syndrome and severity of coronary atherosclerosis. Clinical Endocrinology 2009; 70:876–882.

http://dx.doi.org/10.1111/j.1365-2265.2008.03411.x.

Iacobellis G, Leonetti F. Epicardial adipose tissue and insulin resistance in obese subjects. J Clin Endocrinol Metab. 2005; 90 (11):6300-6302. http://dx.doi.org/10.1210/jc.2005-1087.

Iacobellis G, Barbaro G, Gerstein H. Relationship of epicardial fat thickness and fasting glucose. Int J Cardiol. 2008; 128:424-426.

http://dx.doi.org/10.1016/j.ijcard.2007.12.072.

Iacobellis G, Willens H. Echocardiographic epicardial fat: A review of research and clinical applications. State of the Art Review Article. J Am Soc Echocardiogr. 2009; 22 (12):1311-1319. http://dx.doi.org/ 10.1016/j.echo.2009.10.013.

Rosito G, Massaro J, Hoffmann U, et al. Pericardial fat, visceral abdominal fat, cardiovascular disease risk factors, and vascular calcification in a community-based sample. The Framingham Heart Study. Circulation. 2008; 117 (5):605-613. http://dx.doi.org/10.1161/ CIRCULATIONAHA.107.743062.

Lansang MC, Williams GH, Carroll JS. Correlation between the glucose clamp technique and the homeostatic model assessment in hypertension. Am J Hypertens. 2001; 14 (1):51-53. http://dx.doi.org/ 10.1016/S0895-7061(00)01229-2.

Bakari AG, Onyemelukwe GC. Insulin resistance in type 2 diabetic Nigerians. J Diabetes Metab. 2005; 13:24-27.

Iacobellis G, Ribaudo MC, Assael F, et al. Echocardiographic epicardial adipose tissue is related to anthropometric and clinical parameters of metabolic syndrome: A new indicator of cardiovascular risk. J Clin Endocrinol Metab. 2003; 88 (11): 5163–5168.

http://dx.doi.org/10.1210/jc.2003-030698.

Sade LE, Eroglu S, Bozbas, H, et al. Relationship between epicardial fat thickness and coronary flow reserve in women with chest pain and angiographically normal coronary arteries. Atherosclerosis. 2009; 204 (2):580-585. http://dx.doi.org/10.1016/j.atherosclerosis.2008.09.038.

Iacobellis G, Willens H, Barbaro G, Sharma A. Threshold values of high-risk echocardiographic epicardial fat thickness. Nature Publishing Group, Basingstoke, Obesity. ISSN 2008; 16 (4):887-892.

Bonora E, Kiechl S, Willeit, J, et al. Prevalence of insulin resistance in metabolic disorders: The Bruneck Study. Diabetes. 1998; 47(10):1643-1649. http://dx.doi.org/10.2337/diabetes.47.10.1643.

Hasan A, Ahmet T, Og˘ uzhan D, et al. Epicardial fat tissue thickness correlates with endothelial dysfunction and other cardiovascular risk factors in patients with metabolic syndrome. Metab Syndr Relat D..2010; 8( 3): 229-234.

Hizli S, Ozdemir O, Abazi A, Razi C, Kabakus N. Relationship of subepicardial adipose tissue thickness and clinical and metabolic parameters in obese prepubertal children. Pediatr Diabetes. 2010; 11(8):556-562. http://dx.doi.org/10.1111/j.1399-5448.2010.00644.x

Published

2014-11-29

How to Cite

Tan-Ramos, K. C., Sy, R. A., & Choa, V. (2014). Echocardiographic Epicardial Adipose Tissue Thickness as a Marker of Insulin Resistance. Journal of the ASEAN Federation of Endocrine Societies, 29(2), 129. Retrieved from https://www.asean-endocrinejournal.org/index.php/JAFES/article/view/156

Issue

Section

Original Articles

Most read articles by the same author(s)